Amyris Inc (AMRSQ)

OTC Markets

Currency in USD

0.01

0.00(0.00%)

Closed·06/05

Day's Range

0.00

0.01

52 wk Range

0.00

0.01

AMRSQ Income Statement

Explore the detailed Amyris Inc income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Amyris Inc's growth trends and overall financial health.

Period Ending:

2013

31/12

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

Total Revenues

aa.aa

63.6

152.56

173.14

341.82

269.85

Total Revenues Growth

aa.aa

-50.18%

+139.85%

+13.49%

+97.43%

-21.06%

Cost Of Revenues

aa.aa

105.42

140.65

159.49

260.53

367.58

Gross Profit

aa.aa

-41.82

11.91

13.65

81.29

-97.74

Gross Profit Growth

aa.aa

-635.97%

+128.49%

+14.58%

+495.54%

-220.24%

Gross Profit Margin %

aa.aa

-65.74%

7.81%

7.88%

23.78%

-36.22%

Other Operating Expenses, Total

aa.aa

90.9

133.59

137.07

258.91

494.93

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+42.36%	+46.96%	+2.61%	+88.89%	+91.16%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	90.9	133.59	137.07	258.91	494.93
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-132.72

-121.67

-123.42

-177.63

-592.67

Operating Income Growth

aa.aa

-136.78%

+8.32%

-1.44%

-43.92%

-233.66%

EBIT Margin %

aa.aa

-208.66%

-79.76%

-71.29%

-51.97%

-219.63%

Net Interest Expenses

aa.aa

-42.7

-58.67

-47.95

-25.61

-24.73

Net Interest Expenses Growth

aa.aa

-15.16%

-37.38%

+18.26%

+46.6%

+3.41%

Interest Expense, Total

aa.aa

-42.7

-58.67

-47.95

-25.61

-24.73

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

-33.83

1.99

-13.43

-5.56

-5.75

EBT, Excl. Unusual Items

aa.aa

-209.25

-178.35

-184.8

-208.79

-623.15

Gain (Loss) On Sale Of Assets

aa.aa

-1.78

Other Unusual Items, Total

aa.aa

-19.21

-63.79

-141.78

-71.11

78.27

EBT, Incl. Unusual Items

aa.aa

-230.24

-242.14

-326.58

-279.91

-546.07

EBT, Incl. Unusual Items Growth

aa.aa

-54.41%

-5.17%

-34.87%

+14.29%

-95.09%

EBT, Incl. Unusual Items Margin

aa.aa

-361.98%

-158.72%

-188.63%

-81.89%

-202.36%

Income Tax Expense

aa.aa

0.63

0.29

-8.11

-2.7

Net Income to Company

aa.aa

-230.24

-242.77

-326.87

-271.79

-543.37

Minority Interest

aa.aa

-4.17

0.82

14.86

Net Income

aa.aa

-230.24

-242.77

-331.04

-270.97

-528.51

Net Income Growth

aa.aa

-47.6%

-5.44%

-36.36%

+18.15%

-95.04%

Net Income Margin %

aa.aa

-361.98%

-159.13%

-191.2%

-79.27%

-195.86%

Preferred Dividend and Other Adjustments

aa.aa

-7.14

27.58

51.27

-0.51

Net Income to Common Excl. Extra Items

aa.aa

-223.1

-270.35

-382.31

-270.46

-528.51

Basic EPS - Continuing Operations

aa.aa

-3.69

-2.67

-1.88

-0.93

-1.65

Basic EPS - Continuing Operations Growth

aa.aa

+40.99%

+27.79%

+29.59%

+50.73%

-78.1%

Diluted EPS - Continuing Operations

aa.aa

-3.69

-2.67

-1.88

-0.97

-1.69

Diluted EPS - Continuing Operations Growth

aa.aa

+40.99%

+27.79%

+29.51%

+48.16%

-73.83%

Basic Weighted Average Shares Outstanding

aa.aa

60.41

101.37

203.6

292.34

320.75

Diluted Weighted Average Shares Outstanding

aa.aa

60.41

101.37

203.6

292.67

339.33

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-127.8

-117.09

-114.05

-167.9

-575.85

EBITDA Growth

aa.aa

-185.94%

+8.38%

+2.6%

-47.21%

-242.97%

EBITDA Margin %

aa.aa

-200.93%

-76.75%

-65.87%

-49.12%

-213.4%

EBIT

aa.aa

-132.72

-121.67

-123.42

-177.63

-592.67

* In Millions of USD (except for per share items)

US 30

42,267.50

-247.6

-0.58%

US 500

5,997.10

-36.0

-0.60%

Dow Jones

42,515.09

+317.30

+0.75%

S&P 500

6,033.11

+56.14

+0.94%

Nasdaq

19,701.21

+294.39

+1.52%

S&P 500 VIX

20.63

+1.52

+7.95%

Dollar Index

97.72

+0.168

+0.17%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	144.69	+1.92%	183.13M
AMD	126.39	+8.81%	100.97M
TSLA	329.13	+1.17%	83.93M
PLTR	141.41	+2.92%	80.78M
AAPL	198.42	+1.00%	43.02M
MSFT	479.14	+0.88%	15.63M
META	702.12	+2.82%	13.72M

Trending Stocks

Name	Last	Chg. %	Vol.
TSLA	329.13	+1.17%	83.93M
AMD	126.39	+8.81%	100.97M
NVDA	144.69	+1.92%	183.13M
PLTR	141.41	+2.92%	80.78M
AAPL	198.42	+1.00%	43.02M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa A	131.04	+47.20%	192.89
Aaaaaaa	314.44	+44.47%	454.27
Aaaaaaaaa A	35.11	+43.53%	50.39
Aaaaaaaaaaaa Aa	78.07	+33.87%	104.51
Aaaaaa	25.79	+28.33%	33.10
Aaaaaaaaa A Aa	146.03	+27.80%	186.63
Aaa Aaa	44.41	+27.36%	56.56

Name	Last	Upside	Fair Value
Aaaaaaaaaa A	131.04	+47.20%	192.89
Aaaaaaa	314.44	+44.47%	454.27
Aaaaaaaaa A	35.11	+43.53%	50.39
Aaaaaaaaaaaa Aa	78.07	+33.87%	104.51
Aaaaaa	25.79	+28.33%	33.10
Aaaaaaaaa A Aa	146.03	+27.80%	186.63
Aaa Aaa	44.41	+27.36%	56.56

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Name	Last	Chg. %	Vol.
EL	74.59	+10.82%	6.40M
AMD	126.39	+8.81%	100.97M
MGM	34.30	+8.10%	9.09M
WBD	10.76	+7.28%	46.71M
TPR	84.26	+6.78%	4.22M
CCL	23.84	+6.38%	32.99M
LVS	42.81	+6.15%	6.16M

Name	Last	Chg. %	Vol.
LMT	467.06	-3.99%	2.77M
NOC	497.52	-3.72%	1.17M
LHX	247.77	-3.59%	1.83M
CHTR	375.23	-3.47%	1.47M
MOH	290.25	-2.65%	650.86K
MRNA	26.00	-2.51%	10.67M
FANG	151.03	-2.50%	3.83M

Popular Searches

Please try another search

Amyris Inc (AMRSQ)

AMRSQ Income Statement

Trending Stocks